GlassScriptPhysician profile
Marco A Barzallo
NPI 1316971823
$13,187.56
in general payments reported to CMS, 2019-2025
19 companies · $2,572 in 2025
The $2,572 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,893 · 2020: $443 · 2021: $798 · 2022: $1,211 · 2023: $2,785 · 2024: $2,485 · 2025: $2,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,102 · Travel and Lodging: $2,388 · Entertainment: $269 · Education: $83.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,101.74 |
| Travel and Lodging | $2,387.53 |
| Entertainment | $269.49 |
| Education | $83.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,026.62 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Penumbra, INC. | $3,044.96 | 2019-2025 | Indigo System |
| Abbott Laboratories | $2,441.77 | 2019-2025 | Triclip, Xience Skypoint, Perclose Prostyle |
| Abiomed | $632.90 | 2021-2024 | Impella |
| Cardiva Medical, INC. | $493.79 | 2024-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Opsens INC. | $477.24 | 2022-2023 | Optowire |
| Ge Healthcare | $369.07 | 2024 | |
| Shockwave Medical, INC | $361.09 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $332.78 | 2021-2025 | Hawkone |
| Boston Scientific Corporation | $256.50 | 2019-2025 | Avvigo Guidance System, Watchman Access System |
| Janssen Pharmaceuticals, INC | $233.26 | 2019-2021 | |
| Livanova USA, INC. | $133.10 | 2023 | Lifesparc |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.99 | 2024-2025 | Jardiance |
| Chiesi USA, INC. | $99.80 | 2023 | Kengreal, Cleviprex |
| Getinge USA Sales, LLC | $61.42 | 2023-2024 | Cs300 Intra-Aortic Balloon Pump, English, 110v |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $42.91 | 2023-2025 | Mynxgrip, Mynx Control Venous |
| Bard Peripheral Vascular, INC. | $26.25 | 2024 | Lutonix Drug Coated Balloon |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.31 | 2025 | Lifevest |
| Pfizer INC. | $14.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Barzallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.